Outlook Therapeutics Inc logo

Outlook Therapeutics Inc

NEW
STU:41O (USA)  
€ 0.86 +0.050 (+6.2%) Aug 4
At Loss
Market Cap:
€ 156.43M ($ 180.63M)
Enterprise V:
€ 173.32M ($ 200.13M)
Volume:
8.70K
Avg Vol (2M):
21.39K
Trade In:
Volume:
8.70K
At Loss

Outlook Therapeutics Inc (STU:41O) Dividend

Outlook Therapeutics Inc (STU:41O) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -68%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:41O Dividend

Does Outlook Therapeutics Inc (STU:41O) pay a dividend?

Outlook Therapeutics Inc (STU:41O) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Outlook Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Outlook Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -68% over the past 3 years.

What are dividend-paying alternatives to Outlook Therapeutics Inc?

For dividend-paying alternatives in Outlook Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.